首页> 美国卫生研究院文献>Prostate International >Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate
【2h】

Role of cyclin D1 immunoreactivity and AgNOR staining in the evaluation of benign and malignant lesions of the prostate

机译:细胞周期蛋白D1免疫反应性和AgNOR染色在评估前列腺良恶性病变中的作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Purpose:Prostatic carcinoma is a common and growing public health problem. Histological evaluation is fairly adequate for assessing tumor differentiation, but tumor proliferative activity is difficult to measure. Increasing evidence suggests that the factors controlling cell cycle progression also modulate the rate of ribosome biogenesis. Despite the influence of cyclin D1 and argyrophilic nuclear organizer region (AgNOR) on prostate cancer proliferation, few studies have evaluated the diagnostic importance of these markers. Therefore, the present study was carried out to analyze the diagnostic value of the proliferative markers cyclin D1 and AgNOR in various prostatic lesions and to determine whether any association or relation between these markers and different Gleason grades exists.
机译:目的:前列腺癌是一个常见且日益严重的公共卫生问题。组织学评估足以评估肿瘤的分化,但肿瘤的增殖活性很难测量。越来越多的证据表明,控制细胞周期进程的因素也可以调节核糖体的生物发生速率。尽管细胞周期蛋白D1和嗜银细胞核组织区(AgNOR)对前列腺癌的增殖有影响,但很少有研究评估这些标志物的诊断重要性。因此,本研究旨在分析增殖标志物cyclin D1和AgNOR在各种前列腺病变中的诊断价值,并确定这些标志物与不同Gleason等级之间是否存在任何关联或关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号